📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Nath Bio-Genes Q3 Revenue Surges 79% to ₹660 Mn; PAT Up 67% YoY
Nath Bio-Genes reported a robust 79% YoY revenue growth in Q3FY26, reaching ₹660 million, primarily driven by a massive 142% value growth in the Maize segment. While Q3 PAT rose 67% to ₹45 million, EBITDA margins faced pressure, declining to 13% from 20% YoY. For 9MFY26, the company achieved a 23% revenue increase to ₹3,859 million, though PAT growth remained muted at 1%. The company is successfully diversifying its portfolio, with significant volume gains in Cotton (21%), Paddy (8%), and Vegetables (43%).
Key Highlights
Q3FY26 Revenue increased by 79% YoY to ₹660 million; 9MFY26 Revenue up 23% to ₹3,859 million.
Maize segment witnessed exceptional growth with volume up 94.77% and value up 141.98% YoY.
Q3 EBITDA margin compressed to 13% from 20% YoY, while 9M EBITDA margin stood at 14%.
Cotton segment remains the primary driver with 25.26% value growth in the first nine months.
Vegetable seeds emerged as a fast-growing segment with a 52.08% increase in value during 9MFY26.
💼 Action for Investors
Investors should cheer the strong top-line growth and diversification into high-value crops like Maize and Vegetables, but should closely monitor the impact of rising costs on EBITDA margins.
Nath Bio-Genes Q3 Standalone PAT Jumps 172% to ₹7.23 Cr; Consolidated Profit Declines
Nath Bio-Genes (India) Limited reported a robust standalone performance for Q3 FY26, with revenue growing 79% YoY to ₹65.96 crore and PAT surging 172% to ₹7.23 crore. However, the consolidated net profit for the quarter fell to ₹1.60 crore from ₹2.65 crore YoY, indicating significant losses or expenses within subsidiaries. For the nine-month period ended December 2025, consolidated revenue stood at ₹383.51 crore, up from ₹312.94 crore. Investors should note a qualified auditor's opinion regarding unassessed liabilities from new Labour Codes and the absence of actuarial valuations for employee benefits.
Key Highlights
Standalone Revenue for Q3 FY26 increased 78.9% YoY to ₹65.96 crore from ₹36.87 crore.
Standalone Net Profit for the quarter surged to ₹7.23 crore compared to ₹2.66 crore in the same period last year.
Consolidated Net Profit for Q3 FY26 dropped to ₹1.60 crore, down from ₹2.65 crore in Q3 FY25.
9M FY26 Consolidated Revenue grew 22.5% YoY to ₹383.51 crore from ₹312.94 crore.
Auditors issued a qualified opinion due to the lack of financial impact assessment for new Labour Codes effective Nov 2025.
💼 Action for Investors
Investors should investigate the widening gap between standalone and consolidated profits, as subsidiaries appear to be significantly impacting the bottom line. While standalone growth is strong, the auditor's qualification on labor code liabilities and missing actuarial valuations warrants caution regarding future provisions.